How about we just agree our 'Wonder Drug' 675A coming to the rescue with the inflammation issues that arise out of Covid and many other conditions. Personally, 675A is the dark-horse that could well be our shining light.
PV1 Provaris tells ASX non-binding MOUs are still material to share prices in somewhat fiery compliance response